middle.news
Vitura’s Canview growth meets a sharper profitability test
8:26am on Friday 16th of October, 2026 AEDT
•
Healthcare
Read Story
Vitura’s Canview growth meets a sharper profitability test
8:26am on Friday 16th of October, 2026 AEDT
Key Points
Revenue increased 6% to $131.2 million
Statutory loss of $4.4 million versus FY2025 profit of $3.1 million
Gross margin fell to 19% as medicinal cannabis prices compressed
$14.2 million of ANZ borrowings classified as current after a covenant breach
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Vitura Health (ASX:VIT)
OPEN ARTICLE